Artal International S.C.A. 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 5:08 pm Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal International S.C.A. | 3,568,842 9.900% |
2,105,013 (+143.80%) |
Filing |
| 2023-02-10 7:41 pm Purchase |
2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal International S.C.A. | 1,463,829 7.200% |
1,113,829 (+318.24%) |
Filing |
| 2022-02-11 06:28 am Purchase |
2022-02-02 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal International S.C.A. | 350,000 5.600% |
350,000 (New Position) |
Filing |